Value-Based Medtech: how to succeed in a challenging environment

Adapting To New Medical Device And HTA Regulations

The new Medical Device and HTA Regulations in the EU

demand companies to adapt to new standards for evidence generation and centralized assessments at the EU level. Alongside rapid digitalization and technological advancements, these changes require modernization, restructuring, and acquisition of new managerial skills to maintain competitiveness.

The “Value-Based Medtech” course provides insights on how to navigate and succeed in this evolving landscape. It covers the consequences of the new EU Regulations on the medtech ecosystem, current and future trajectories of the HTA, evidence generation, evaluation processes and methods, value-based procurement, payment schemes and pricing for medical devices.

To gain understanding of key challenges in the medtech sector, including the impact of ongoing changes in international regulatory science for technological advancement in healthcare, the lifecycle evidence generation and assessment for medical devices, the evolving role and scope of HTA, and innovative policies such as value-based procurement and pricing.

Pillar I

Key challenges of the medical device sector